Teplizumab is an antibody that targets the CD3 receptor on T-cells to prevent the T-cells from attacking the Insulin-producing Beta cells in the pancreas. How is the teplizumab able to specifically inhibit only the T-cells targeting the B-cells without compromising the immune system?

Upvotes: 710